Insomnia in Postmenopausal Women: How to Approach and Treat It?
Insomnia is one of the major complaints of menopausal women with advancing age and may be complexly related to a variety of causes. However, there is still a lack of standards on the general approach and treatment for insomnia in menopausal women. The aim of this review is to summarize recent pathog...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical medicine 2024-01, Vol.13 (2), p.428 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | 428 |
| container_title | Journal of clinical medicine |
| container_volume | 13 |
| creator | Jeon, Gyun-Ho |
| description | Insomnia is one of the major complaints of menopausal women with advancing age and may be complexly related to a variety of causes. However, there is still a lack of standards on the general approach and treatment for insomnia in menopausal women. The aim of this review is to summarize recent pathogenic theories of sleep disturbance in the menopausal period and discuss the approach and management of insomnia in postmenopausal women. Sleep disturbances in menopausal women may be associated with physical and psychiatric factors and other comorbid diseases. Careful history taking and multidisciplinary physical and psychosocial evaluation are necessary and, in particular, comorbidities related to sleep disorders, such as obstructive sleep apnea, must be taken into consideration. A unique aspect of insomnia in postmenopausal women is that menopausal symptoms due to hormonal decline can be closely related to sleep disturbances. Therefore, menopausal hormone therapy (MHT) should be considered as the treatment of choice among pharmacological treatments following cognitive behavioral therapy, which is suggested as the first-line treatment in the general population insomnia treatment guidelines. Additionally, melatonin and 5HT-based drugs, which have fewer side effects, along with MHT should be preferentially recommended in menopausal women. |
| doi_str_mv | 10.3390/jcm13020428 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2917867202</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A780877247</galeid><sourcerecordid>A780877247</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-e4bf1f4543d30bf9e8d80641c68091c0b04b8a1cc612248aa0f8e8a2fcbe767d3</originalsourceid><addsrcrecordid>eNptkc9LwzAUx4MobsydvEvAiyCd-dUm9TLGUDcQ9DDxWNI00Y42qU2L-N-bsalTfO_wfvB5jy98ATjFaEJpiq7WqsYUEcSIOABDgjiPEBX0cK8fgLH3axRCCEYwPwYDKkicxAkZgunSelfbUsLSwkfnu1pb18jeywo-uzBcw4V7h52Ds6ZpnVSvUNoCrlotO7jspifgyMjK6_GujsDT7c1qvojuH-6W89l9pChPu0iz3GDDYkYLinKTalEIlDCsEoFSrFCOWC4kVirBhDAhJTJCC0mMyjVPeEFH4GL7N4h467Xvsrr0SleVtNr1PiMp5iLhBJGAnv9B165vbVC3oQTnNE7FD_UiK52V1riulWrzNJtxgQJGGA_U5B8qZKHrUjmrTRn2vw4utweqdd632mRNW9ay_cgwyjaOZXuOBfpsJ7XPa118s1_-0E8bEozR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918773598</pqid></control><display><type>article</type><title>Insomnia in Postmenopausal Women: How to Approach and Treat It?</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Jeon, Gyun-Ho</creator><creatorcontrib>Jeon, Gyun-Ho</creatorcontrib><description>Insomnia is one of the major complaints of menopausal women with advancing age and may be complexly related to a variety of causes. However, there is still a lack of standards on the general approach and treatment for insomnia in menopausal women. The aim of this review is to summarize recent pathogenic theories of sleep disturbance in the menopausal period and discuss the approach and management of insomnia in postmenopausal women. Sleep disturbances in menopausal women may be associated with physical and psychiatric factors and other comorbid diseases. Careful history taking and multidisciplinary physical and psychosocial evaluation are necessary and, in particular, comorbidities related to sleep disorders, such as obstructive sleep apnea, must be taken into consideration. A unique aspect of insomnia in postmenopausal women is that menopausal symptoms due to hormonal decline can be closely related to sleep disturbances. Therefore, menopausal hormone therapy (MHT) should be considered as the treatment of choice among pharmacological treatments following cognitive behavioral therapy, which is suggested as the first-line treatment in the general population insomnia treatment guidelines. Additionally, melatonin and 5HT-based drugs, which have fewer side effects, along with MHT should be preferentially recommended in menopausal women.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm13020428</identifier><identifier>PMID: 38256562</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Aging ; Anxiety ; Behavior therapy ; Body temperature ; Care and treatment ; Circadian rhythm ; Cognitive therapy ; Comorbidity ; Complaints ; Diagnosis ; Drospirenone ; Emotional disorders ; Endocrine therapy ; Estrogens ; Eszopiclone ; Eye movements ; Females ; Hormone therapy ; Hormones ; Insomnia ; Melatonin ; Menopause ; Mental depression ; Methods ; Middle age ; Mood disorders ; Physiology ; Postmenopausal women ; Psychological aspects ; Psychotherapy ; Ramelteon ; Restless legs syndrome ; Risk factors ; Sleep apnea ; Sleep apnea syndromes ; Sleep disorders ; Sweating ; Womens health</subject><ispartof>Journal of clinical medicine, 2024-01, Vol.13 (2), p.428</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c379t-e4bf1f4543d30bf9e8d80641c68091c0b04b8a1cc612248aa0f8e8a2fcbe767d3</cites><orcidid>0000-0003-1128-1656</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38256562$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jeon, Gyun-Ho</creatorcontrib><title>Insomnia in Postmenopausal Women: How to Approach and Treat It?</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Insomnia is one of the major complaints of menopausal women with advancing age and may be complexly related to a variety of causes. However, there is still a lack of standards on the general approach and treatment for insomnia in menopausal women. The aim of this review is to summarize recent pathogenic theories of sleep disturbance in the menopausal period and discuss the approach and management of insomnia in postmenopausal women. Sleep disturbances in menopausal women may be associated with physical and psychiatric factors and other comorbid diseases. Careful history taking and multidisciplinary physical and psychosocial evaluation are necessary and, in particular, comorbidities related to sleep disorders, such as obstructive sleep apnea, must be taken into consideration. A unique aspect of insomnia in postmenopausal women is that menopausal symptoms due to hormonal decline can be closely related to sleep disturbances. Therefore, menopausal hormone therapy (MHT) should be considered as the treatment of choice among pharmacological treatments following cognitive behavioral therapy, which is suggested as the first-line treatment in the general population insomnia treatment guidelines. Additionally, melatonin and 5HT-based drugs, which have fewer side effects, along with MHT should be preferentially recommended in menopausal women.</description><subject>Aging</subject><subject>Anxiety</subject><subject>Behavior therapy</subject><subject>Body temperature</subject><subject>Care and treatment</subject><subject>Circadian rhythm</subject><subject>Cognitive therapy</subject><subject>Comorbidity</subject><subject>Complaints</subject><subject>Diagnosis</subject><subject>Drospirenone</subject><subject>Emotional disorders</subject><subject>Endocrine therapy</subject><subject>Estrogens</subject><subject>Eszopiclone</subject><subject>Eye movements</subject><subject>Females</subject><subject>Hormone therapy</subject><subject>Hormones</subject><subject>Insomnia</subject><subject>Melatonin</subject><subject>Menopause</subject><subject>Mental depression</subject><subject>Methods</subject><subject>Middle age</subject><subject>Mood disorders</subject><subject>Physiology</subject><subject>Postmenopausal women</subject><subject>Psychological aspects</subject><subject>Psychotherapy</subject><subject>Ramelteon</subject><subject>Restless legs syndrome</subject><subject>Risk factors</subject><subject>Sleep apnea</subject><subject>Sleep apnea syndromes</subject><subject>Sleep disorders</subject><subject>Sweating</subject><subject>Womens health</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNptkc9LwzAUx4MobsydvEvAiyCd-dUm9TLGUDcQ9DDxWNI00Y42qU2L-N-bsalTfO_wfvB5jy98ATjFaEJpiq7WqsYUEcSIOABDgjiPEBX0cK8fgLH3axRCCEYwPwYDKkicxAkZgunSelfbUsLSwkfnu1pb18jeywo-uzBcw4V7h52Ds6ZpnVSvUNoCrlotO7jspifgyMjK6_GujsDT7c1qvojuH-6W89l9pChPu0iz3GDDYkYLinKTalEIlDCsEoFSrFCOWC4kVirBhDAhJTJCC0mMyjVPeEFH4GL7N4h467Xvsrr0SleVtNr1PiMp5iLhBJGAnv9B165vbVC3oQTnNE7FD_UiK52V1riulWrzNJtxgQJGGA_U5B8qZKHrUjmrTRn2vw4utweqdd632mRNW9ay_cgwyjaOZXuOBfpsJ7XPa118s1_-0E8bEozR</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Jeon, Gyun-Ho</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1128-1656</orcidid></search><sort><creationdate>20240101</creationdate><title>Insomnia in Postmenopausal Women: How to Approach and Treat It?</title><author>Jeon, Gyun-Ho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-e4bf1f4543d30bf9e8d80641c68091c0b04b8a1cc612248aa0f8e8a2fcbe767d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aging</topic><topic>Anxiety</topic><topic>Behavior therapy</topic><topic>Body temperature</topic><topic>Care and treatment</topic><topic>Circadian rhythm</topic><topic>Cognitive therapy</topic><topic>Comorbidity</topic><topic>Complaints</topic><topic>Diagnosis</topic><topic>Drospirenone</topic><topic>Emotional disorders</topic><topic>Endocrine therapy</topic><topic>Estrogens</topic><topic>Eszopiclone</topic><topic>Eye movements</topic><topic>Females</topic><topic>Hormone therapy</topic><topic>Hormones</topic><topic>Insomnia</topic><topic>Melatonin</topic><topic>Menopause</topic><topic>Mental depression</topic><topic>Methods</topic><topic>Middle age</topic><topic>Mood disorders</topic><topic>Physiology</topic><topic>Postmenopausal women</topic><topic>Psychological aspects</topic><topic>Psychotherapy</topic><topic>Ramelteon</topic><topic>Restless legs syndrome</topic><topic>Risk factors</topic><topic>Sleep apnea</topic><topic>Sleep apnea syndromes</topic><topic>Sleep disorders</topic><topic>Sweating</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jeon, Gyun-Ho</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Proquest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jeon, Gyun-Ho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insomnia in Postmenopausal Women: How to Approach and Treat It?</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>13</volume><issue>2</issue><spage>428</spage><pages>428-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Insomnia is one of the major complaints of menopausal women with advancing age and may be complexly related to a variety of causes. However, there is still a lack of standards on the general approach and treatment for insomnia in menopausal women. The aim of this review is to summarize recent pathogenic theories of sleep disturbance in the menopausal period and discuss the approach and management of insomnia in postmenopausal women. Sleep disturbances in menopausal women may be associated with physical and psychiatric factors and other comorbid diseases. Careful history taking and multidisciplinary physical and psychosocial evaluation are necessary and, in particular, comorbidities related to sleep disorders, such as obstructive sleep apnea, must be taken into consideration. A unique aspect of insomnia in postmenopausal women is that menopausal symptoms due to hormonal decline can be closely related to sleep disturbances. Therefore, menopausal hormone therapy (MHT) should be considered as the treatment of choice among pharmacological treatments following cognitive behavioral therapy, which is suggested as the first-line treatment in the general population insomnia treatment guidelines. Additionally, melatonin and 5HT-based drugs, which have fewer side effects, along with MHT should be preferentially recommended in menopausal women.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38256562</pmid><doi>10.3390/jcm13020428</doi><orcidid>https://orcid.org/0000-0003-1128-1656</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2077-0383 |
| ispartof | Journal of clinical medicine, 2024-01, Vol.13 (2), p.428 |
| issn | 2077-0383 2077-0383 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2917867202 |
| source | PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Aging Anxiety Behavior therapy Body temperature Care and treatment Circadian rhythm Cognitive therapy Comorbidity Complaints Diagnosis Drospirenone Emotional disorders Endocrine therapy Estrogens Eszopiclone Eye movements Females Hormone therapy Hormones Insomnia Melatonin Menopause Mental depression Methods Middle age Mood disorders Physiology Postmenopausal women Psychological aspects Psychotherapy Ramelteon Restless legs syndrome Risk factors Sleep apnea Sleep apnea syndromes Sleep disorders Sweating Womens health |
| title | Insomnia in Postmenopausal Women: How to Approach and Treat It? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T04%3A22%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insomnia%20in%20Postmenopausal%20Women:%20How%20to%20Approach%20and%20Treat%20It?&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Jeon,%20Gyun-Ho&rft.date=2024-01-01&rft.volume=13&rft.issue=2&rft.spage=428&rft.pages=428-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm13020428&rft_dat=%3Cgale_proqu%3EA780877247%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2918773598&rft_id=info:pmid/38256562&rft_galeid=A780877247&rfr_iscdi=true |